Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Lamivudine monotherapy best bet in preventing HBV recurrence

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Dan YY, Wai CT, Yeoh KG, Lim SG.Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis. Liver Transplantation 12: 736-746, No. 5, May 2006

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Lamivudine monotherapy best bet in preventing HBV recurrence. Pharmacoecon. Outcomes News 508, 4 (2006). https://doi.org/10.2165/00151234-200605080-00011

    Download citation

    Keywords

    • Renal Replacement Therapy
    • Lamivudine
    • Adefovir
    • Undergo Liver Transplant
    • Adefovir Dipivoxil